Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder of
childhood. Although abnormalities in several brain regions and disturbances of the …

The psychostimulant methylphenidate (MPH) is the first-line pharmacological treatment for
attention-deficit/hyperactivity disorder (ADHD), but has numerous adverse side effects. The …

Neurodegeneration is a side effect of methylphenidate (MPH), and minocycline possesses
neuroprotective properties. This study aimed to investigate the neuroprotective effects of …

Aims Insulin resistance (IR) has become one of the major causative factors for the
pathogenesis of various metabolic and neurometabolic diseases. The sedentary lifestyle in …

Background: Medium-chain triglycerides such as decanoic acid (C10), which is one of the
fatty acids that constitute dietary fats, are of substantial interest for their potential therapeutic …

Atomoxetine (ATX) is a presynaptic norepinephrine transporter (NET) inhibitor widely
prescribed for attention-deficit/hyperactivity disorder (ADHD) due to its low abuse potential …

Benzodiazepine (BZD) abuse is a global problem, including pregnant women. For this
population, the drug of choice is usually alprazolam, which acts as a GABAergic agonist and …

Аннотация В статье рассматривается роль воспалительных реакций в формировании
синдрома дефицита внимания с гиперактивностью (СДВГ). На широком и современном …

The article discusses the role of inflammatory reactions in the formation of attention deficit
hyperactivity disorder (ADHD). Based on a wide and modern material, the mechanisms of …

Drug abuse is a major issue worldwide. Methylphenidate (MPH) and alprazolam (ALZ) are
commonly prescribed drugs for the treatment of ADHD and anxiety disorders, respectively …